Intervention

Capsaicin

ClinicalTrials.gov intervention label

Clinical trials7

Recruiting0

Common conditions10

Lead sponsors shown6

Clinical trials

7 shown

Evaluation in the Treatment of Neuropathic Pain Post Breast SurgeryNCT03794388 · 2019-03-19

Capsaicin Energy Expenditure and Glucose MetabolismNCT03859583 · 2018-05-29

Airway Protective Mechanisms in PD (R01)NCT03321019 · 2017-12-12

Capsaicin Effect on Cytokines Profile in DyslipidemiaNCT02823912 · 2016-10-01

Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's DiseaseNCT02183519 · 2014-10-01

Study With Two Capsaicin Topic Treatments in Diabetic Neuropathy.NCT05029297 · 2010-11-04

Efficacy and Safety Study of Topical Capsaicin in Painful Diabetic NeuropathyNCT00993070 · 2009-10-01

Common conditions

Breast Cancer Patient1 Cough1 Diabetic Neuropathy, Painful1 Diabetic Polyneuropathy1 Dyslipidemia1 Insulin Resistance1 Obesity1 Overweight or Obesity1 Parkinson Disease1 Parkinson's Disease1

Leading sponsors

University of Florida2 Arafarma Group, S.A.1 George Mason University1 Institut Cancerologie de l'Ouest1 Thammasat University1 University of Guadalajara1

Trial status mix

COMPLETED5

UNKNOWN2

Phase mix

PHASE34

PHASE23

NA1

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.